Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Blanchette

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
Journal of Pediatric Hematology/Oncology|November 11, 2003
Desmopressin (DDAVP) responsiveness in children with von Willebrand diseaseShoshana Revel-Vilk, Markus Schmugge, Manuel D Carcao, et al.
Oncology (Williston Park, N.Y.)|November 27, 2018
Bone-Targeted Therapy in Early Breast CancerKatarzyna J Jerzak, Jacques Raphael, Danielle N Desautels, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2006
Comparing two measures of quality of life for children with haemophilia: the CHO-KLAT and the Haemo-QoLC S Bradley, M Bullinger, P J McCusker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 1, 2023
Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia AMichael Shu, Caroline Malcolmson, Vanessa Bouskill, et al.
Journal of Pediatric Hematology/Oncology|July 31, 2004
Reliability and reproducibility of classification of children as "bleeders" versus "non-bleeders" using a questionnaire for significant mucocutaneous bleedingIris Hedlund-Treutiger, Shoshana Revel-Vilk, Victor S Blanchette, et al.
The Journal of Pediatrics|December 1, 1993
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpuraV S Blanchette, B Luke, M Andrew, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 22, 2008
The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis surveyT T Biss, A K Chan, V S Blanchette, et al.
Pediatric Blood & Cancer|October 6, 2005
How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia?Nancy L Young, Catharine S Bradley, Cindy D Wakefield, et al.
BMC Medical Informatics and Decision Making|October 8, 2013
The value of usability testing for Internet-based adolescent self-management interventions: "Managing Hemophilia Online"Vicky R Breakey, Ashley V Warias, Danial M Ignas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Acquired von Willebrand disease in Wilms' tumor patientsM J Coppes, S W Zandvoort, C R Sparling, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
Journal of Pediatric Hematology/Oncology|November 11, 2003
Desmopressin (DDAVP) responsiveness in children with von Willebrand diseaseShoshana Revel-Vilk, Markus Schmugge, Manuel D Carcao, et al.
Oncology (Williston Park, N.Y.)|November 27, 2018
Bone-Targeted Therapy in Early Breast CancerKatarzyna J Jerzak, Jacques Raphael, Danielle N Desautels, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2006
Comparing two measures of quality of life for children with haemophilia: the CHO-KLAT and the Haemo-QoLC S Bradley, M Bullinger, P J McCusker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 1, 2023
Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia AMichael Shu, Caroline Malcolmson, Vanessa Bouskill, et al.
Journal of Pediatric Hematology/Oncology|July 31, 2004
Reliability and reproducibility of classification of children as "bleeders" versus "non-bleeders" using a questionnaire for significant mucocutaneous bleedingIris Hedlund-Treutiger, Shoshana Revel-Vilk, Victor S Blanchette, et al.
The Journal of Pediatrics|December 1, 1993
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpuraV S Blanchette, B Luke, M Andrew, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 22, 2008
The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis surveyT T Biss, A K Chan, V S Blanchette, et al.
Pediatric Blood & Cancer|October 6, 2005
How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia?Nancy L Young, Catharine S Bradley, Cindy D Wakefield, et al.
BMC Medical Informatics and Decision Making|October 8, 2013
The value of usability testing for Internet-based adolescent self-management interventions: "Managing Hemophilia Online"Vicky R Breakey, Ashley V Warias, Danial M Ignas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Acquired von Willebrand disease in Wilms' tumor patientsM J Coppes, S W Zandvoort, C R Sparling, et al.
Pageof 20